Hosted on MSN

PureHealth introduces pilot phase of “Nada”, an AI-based tool to assist doctors in documenting medical notes during patient visits

PureHealth, the largest healthcare group in the Middle East, has announced the launch of the pilot phase of “Nada”, an AI-powered service that functions as a secure digital assistant, supporting ...
Morningstar

BioLineRx Announces New Pilot Phase Data from Phase 2 Combination Trial of Motixafortide in First-Line Pancreatic Cancer (PDAC) to be Presented at ASCO 2025 Annual Meeting

TEL AVIV, Israel, May 30, 2025 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ/TASE: BLRX), a development stage biopharmaceutical company pursuing life-changing therapies in oncology and rare disease, today ...
Seeking Alpha

BioLineRx Announces Encouraging Data from Pilot Phase of Phase 2 Combination Clinical Trial with Motixafortide in First-Line Pancreatic Cancer (PDAC)

- 6 of 11 Patients in the Pilot Phase Experienced a Partial Response, with 4 Confirmed; One Patient Experienced Resolution of the Hepatic Metastatic Lesion - - Data Presented at AACR Special ...
Hosted on MSN

PureHealth introduces pilot phase of 'Nada' AI-based tool to assist doctors in documenting medical notes

ABU DHABI, 29th December, 2025 (WAM) -- PureHealth, the largest healthcare group in the Middle East, has announced the launch of the pilot phase of “Nada”, an AI-powered service that functions as a ...